Editas Medicine Expands Leadership Team With Key Organizational Appointments
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Editas Medicine, a leading genome editing company, today announced the appointment of Timothy D. Hunt as senior vice president of corporate affairs and Haiyan Jiang, Ph.D., as vice president of preclinical science.
“The addition of Tim and Haiyan expands and strengthens our leadership team,” said Katrine Bosley, CEO, Editas Medicine.
“The addition of Tim and Haiyan expands and strengthens our leadership team,” said Katrine Bosley, CEO, Editas Medicine.